Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-079700
Filing Date
2023-07-10
Accepted
2023-07-10 17:01:03
Documents
1
Period of Report
2023-07-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2320966-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2320966-1_4seq1.xml 4 5536
  Complete submission text file 0001104659-23-079700.txt   7104
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Menzel Garry E (Reporting) CIK: 0001556064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 231080432

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)